Question · Q3 2025
Hassan Ahmed sought granularity on Celanese's near-term guidance, specifically the path to a $2/share quarterly EPS run rate via self-help and reduced interest expense, and views on anti-involution impacting the acetyls chain in China.
Answer
President and CEO Scott Richardson reiterated focus on controllable actions to reach the $2 run rate, noting that cost actions and the EM pipeline position them near $1.75-$2, with any demand improvement closing the gap. He acknowledged the palpable dialogue on anti-involution in China, expecting it to be an important step for asset profitability, though direct impact is hard to quantify.